As the healthcare landscape continues its rapid change, pharmaceutical companies are revising their operating models to be more customer-centric and to have greater collaboration with providers.

Developing a customer-centric commercial business model

John Finan, director with Baker Tilly joined the healthcare consulting team in 2017. He is a member of the life sciences advisory practice and leads Baker Tilly’s new pharmaceutical commercial excellence practice. The practice provides trusted advisory services for life science clients with growth optimization expectations through the design & deployment of a product’s development and launch.

University of Hartford
Master of Business Administration

University of Rhode Island
Bachelor of Science in business administration

http://go.bakertilly.com/directory-lp?Directory=John%20Finan

18 years pharma industry experience serving commercial roles from sales representative, medical education, field sales management, product management to Vice President of sales and marketing

Life Science Market Access Optimization team

Provided clients with extensive experience and expertise designing pre-launch access and adaptability platforms

Produced impactful and targeted commercial growth initiatives for both fast-tract launch and in-line market expansion

Senior vice president, chief commercial officer, transition patient services

Retail pharmacy and patient HUB support service

Provided trade, distribution and pharmaceutical treatment transition from hospital to home services to the pharmaceutical industry

Director, commercial operations practices, PwC

Led commercial effectiveness advisory practice and function as lead advisory for strategic and tactical execution guidance

Product development and launch strategy in retail

­Institutional and DoD/ VHA customer channels

Design and construction of infrastructure and business policy for an in-house patient support HUB service for a global biopharma

­Design and construction of new business units with a focus on self-insured employers for a major pharma

Commercial transformations for pharma, diagnostic and device clients

AdvaMed – Medical Device Industry Trade Group

Effective market access strategies are the secret sauce for achieving gateways to customer adoption of your products. However, health plans often invoke prior authorizations on products for which they do not have outright positive coverage – and with a larger volume of specialty products and diagnostic procedures, life sciences organizations are facing prior authorizations for their products at an increasing rate. This additional step in product coverage poses severe challenges in getting these innovative products into the hands of patients and related challenges in reimbursement. So, how can organizations better prepare to handle this new volume of prior authorizations to ensure high levels of market access? Join Baker Tilly, the Accreditation Council for Medical Affairs (ACMA) and the National Board of Prior Authorization Specialists (NBPAS) for the second in a three part series of webinars. This informative session will discuss the challenges occurring in market access with a focus on prior authorizations and steps organizations can take to strategically address them through enhancement initiatives, accreditation measures and training programs. Our team of Value Architects™ and trusted partners will discuss:  How proper organizational preparedness and open conversation around prior authorizations can improve market access and reimbursement of an organization’s products How organizations can empower their field force and customers to successfully navigate prior authorizations How the certified training of the field force can help to build value and trust Who should attend? Commercial executives and professionals, market access executives and professionals, sales and marketing, and operations professionals Presenters Mark Scallon, Baker Tilly Life Sciences Advisory, Principal John Finan, Baker Tilly Life Sciences Advisory, Director Amanda DeMarzo, ACMA, Associate Director of Patient Access  Learning objectives Understand how proper organizational preparedness and open conversation around prior authorizations can improve market access and reimbursement of an organization’s products Comprehend how organizations can empower their field force and customers to successfully navigate prior authorizations Know how the certified training of the field force can help to build value and trust Information about CPE eligibility                                                                  There are no prerequisites for this webinar, and advance preparation is not required. There is no cost to attend this webinar. Level: Overview CPE credit: One (1) hour total credit Field of study: Management Advisory Services  A certificate of completion will be emailed to you four to six weeks after the event. For more information regarding administrative policies such as complaint and refund, please contact our offices at +1 (608) 240 2522.  Baker Tilly US, LLP is registered with the National Association of State Boards of Accountancy (NASBA) as a sponsor of continuing professional education on the National Registry of CPE Sponsors. State boards of accountancy have final authority on the acceptance of individual courses for CPE credit. Complaints regarding registered sponsors may be submitted to the National Registry of CPE Sponsors through its website: learningmarket.org.

John Finan

Location

Education

Expertise

John's latest insights

Developing a customer-centric commercial business model

John's upcoming events

Webinar

Prior authorization: one of the biggest challenges in market access